Decoding GLP-1: A Guide for Friends and Family of Those On The Pen

You’ve probably heard of “the new weight loss shots” like Wegovy® (semaglutide), Ozempic® (semaglutide), Mounjaro® (tirzepatide), or Zepbound® (tirzepatide)—but here’s the thing: they’re so much more than that. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen dives deep to help you understand what these medications really do and how they’re changing lives in ways far beyond weight loss.

This guide takes readers on an insightful journey through the history and the science behind GLP-1 medications, as well as the challenges many face in accessing them. It goes beyond the headlines to explore the emotional and social realities of living with obesity and how these treatments are offering hope where there was little before.

Featuring real-life stories from the On The Pen community, Decoding GLP-1 shares the personal triumphs, challenges, and transformations of those who’ve walked this path. These firsthand accounts bring a deeply human perspective to the science, showing just how powerful these medications can be.

Whether you’re a spouse, parent, friend, or coworker, this guide will help you support someone on GLP-1 medications with understanding and empathy. Learn what the future holds for these groundbreaking treatments and how they’re reshaping the fight against obesity.

With easy-to-digest explanations, heartfelt stories, and practical advice, Decoding GLP-1 is the go-to resource for walking alongside someone on this life-changing journey.

Perfect for:

• Friends and family of those using GLP-1 medications.
• Anyone curious about the deeper impact of GLP-1 treatments beyond weight loss.
• Advocates for a better understanding of obesity and its treatments.

Let’s rewrite the narrative around obesity and see these medications for what they truly are—tools for transformation, health, and hope.

Dave Knapp is a leading voice in the GLP-1 medication community, known for his patient-centric approach to sharing information about weight loss, obesity, and type 2 diabetes. Through his platform On The Pen, Dave has built a thriving community of over 100,000 individuals navigating their journeys with GLP-1 medications.
 
A social media influencer, podcaster, and content creator, Dave delivers timely, relatable, and deeply informed insights that resonate with patients. His work has been featured in Fortune, Bloomberg, Yahoo Finance, and Business Insider, solidifying his role as a trusted advocate and storyteller in the space.
 
Dave's ability to simplify complex topics while centering the patient experience has made him a go-to resource for anyone on or considering GLP-1 treatments. Whether through his engaging live shows, podcasts, or written work, Dave's mission remains clear: to reduce stigma, educate, and empower individuals to reclaim their health.
 
When he's not creating content or connecting with his audience, Dave enjoys spending time with his family, his golden retriever, and sharing personal reflections that inspire others to stay the course.
 
Search "On The Pen" and sttay connected with Dave!